Skip to main content

HEALTH

  • Takeda settles patent suits relating to Actos

    DEERFIELD, Ill., and OSAKA, Japan — Takeda and its subsidiary settled the patent suits it brought against generic drug makers that sought to develop their own versions of its diabetes treatment.

  • Novo Nordisk, Emisphere enter insulin deal

    PRINCETON, N.J. — A biopharmaceutical company exclusively will develop and commercialize oral formulations of a drug maker's insulins.

    Emisphere will be paid $57.5 million in potential product development and sales milestone payments by Novo Nordisk — of which $5 million dollars will be payable upon signing — as well as royalties on sales. Further financial details of the agreement were not disclosed.

  • NPA awards 500th NPA Natural Seal certification

    WASHINGTON — The Natural Products Association last week reached a new milestone — awarding the 500th certification to products and ingredients under the NPA Natural Seal, a certification program focused on the verification of natural products and ingredients.

  • CRN/AANP/AANPF initiative emphasizes role of NPs in health care

    WASHINGTON — The Council for Responsible Nutrition on Monday announced plans for a joint education effort with the American Academy of Nurse Practitioners and the American Academy of Nurse Practitioners Foundation to help raise the level of awareness within the supplement industry and with consumers about the valuable role of nurse practitioners in the quest for good health.

  • Study: Many women aren't being screened for gestational diabetes

    MADISON, N.J. — Nearly one-third of pregnant women are not being screened by a laboratory test for gestational diabetes mellitus (gestational diabetes), according to a study of more than 900,000 American women published online Tuesday on the Obstetrics and Gynecology site.

  • Vicks huddles up with Drew Brees to find most dedicated NFL fan

    CINCINNATI — Procter & Gamble brands Vicks DayQuil and Vicks NyQuil last week kicked off its “Search for the Most Dedicated NFL Fan” — a new Facebook contest featuring two tickets to Super Bowl XLV as the top prize.

    P&G has partnered with New Orleans Saints quarterback Drew Brees to help get the word out about the contest.

    Fans who visit Facebook.com/NyQuil will choose the finalist they feel is most deserving of the two Super Bowl tickets and embodies the spirit of the most dedicated fan among 32 fan finalists, one from each NFL team.

  • Nestlé focuses on science of health

    VEVEY, Switzerland — With the new year approaching, Nestlé Health Science S.A. and the Nestlé Institute of Health Sciences — both created to pioneer a new industry between food and pharma — became operational.

  • Amylin's lipodystrophy treatment granted orphan-drug, fast-track designations

    SAN DIEGO — Drug maker Amylin Pharmaceuticals has submitted the first of a series of sections of a regulatory approval application for a biotech drug to treat patients with a rare lipid disorder.

X
This ad will auto-close in 10 seconds